Cargando…
374 Identification of Psychosis Risk Biomarkers in 22q11DS for future translational studies
OBJECTIVES/GOALS: 22q.11 deletion syndrome (22q11DS) is a genomic syndrome that elevates risk for psychosis >20-fold. We used a battery of cognitive and psychophysiological psychosis-risk biomarkers in 22q11DS patients and healthy subjects in order to identify biomarkers of psychosis in 22q11DS t...
Autores principales: | Parker, David, Imes, Sid, Ruben, Gabrielle, Cuthbert, Bruce, Hershey, Brett, Walker, Elaine, Ousley, Opal, Cubells, Joseph, Duncan, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129592/ http://dx.doi.org/10.1017/cts.2023.412 |
Ejemplares similares
-
Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes
por: Parker, David A., et al.
Publicado: (2023) -
Examining the Overlap between Autism Spectrum Disorder and 22q11.2 Deletion Syndrome
por: Ousley, Opal, et al.
Publicado: (2017) -
Identifying neurodevelopmental anomalies of white matter microstructure associated with high risk for psychosis in 22q11.2DS
por: Bagautdinova, Joëlle, et al.
Publicado: (2020) -
Altered developmental trajectories of verbal learning skills in 22q11.2DS: associations with hippocampal development and psychosis
por: Latrèche, Caren, et al.
Publicado: (2023) -
54443 Pharmacogenomic Profiling of East and West African Populations
por: Jackson, Linsey, et al.
Publicado: (2021)